SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-15-109640
Filing Date
2015-03-27
Accepted
2015-03-27 17:14:54
Documents
8
Period of Report
2015-06-04

Document Format Files

Seq Description Document Type Size
1 PRE 14A d895439dpre14a.htm PRE 14A 488732
2 GRAPHIC g895439dsp_003.jpg GRAPHIC 14384
3 GRAPHIC g895439dsp_044a.jpg GRAPHIC 53158
4 GRAPHIC g895439dsp_044b.jpg GRAPHIC 46245
5 GRAPHIC g895439dsp_044c.jpg GRAPHIC 18148
6 GRAPHIC g895439dsp_044d.jpg GRAPHIC 19763
7 GRAPHIC g895439dsp_044e.jpg GRAPHIC 44816
8 GRAPHIC g895439dsp_045.jpg GRAPHIC 21258
  Complete submission text file 0001193125-15-109640.txt   791062
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-22873 | Film No.: 15731818
SIC: 2835 In Vitro & In Vivo Diagnostic Substances